Ophirex Completes $37 Million Series B Financing to Advance Development of Broad-Spectrum Snakebite Treatment
Business Wire
CORTE MADERA, Calif.--(BUSINESS WIRE)--Ophirex, Inc., a public benefit biotechnology company, today announced the successful..